Pathogenesis of psoriasis in the "omic" era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
- PMID: 32994764
- PMCID: PMC7507147
- DOI: 10.5114/ada.2020.98284
Pathogenesis of psoriasis in the "omic" era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
Abstract
Psoriasis is a systemic disease that is strictly connected with metabolic disorders (insulin resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It occurs more often in patients with a more severe course of the disease. Obesity is specially an independent risk factor and it is associated with a worse treatment outcome because of the high inflammatory activity of visceral fatty tissue and the production of inflammatory mediators involved in the development of both psoriasis and metabolic disorders. However, in psoriasis the activation of the Th17/IL-17 and the abnormalities in the Th17/Treg balance axis are observed, but this pathomechanism does not fully explain the frequent occurrence of metabolic disorders. Therefore, there is a need to look for better biomarkers in the diagnosis, prognosis and monitoring of concomitant disorders and therapeutic effects in psoriasis. In addition, the education on the use of a proper diet as a prophylaxis for the development of the above disorders is an important element of holistic care for a patient with psoriasis. Diet may affect gene expression due to epigenetic modification which encompasses interactions of environment, nutrition and diseases. Patients with psoriasis should be advised to adopt proper diet and dietician support.
Keywords: inflammation; metabolic syndrome; metabolomics; proteomic nutrigenomics; psoriasis.
Copyright: © 2020 Termedia Sp. z o. o.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Compounds of psoriasis with obesity and overweight.Postepy Hig Med Dosw (Online). 2017 Aug 24;71(1):761-772. doi: 10.5604/01.3001.0010.3854. Postepy Hig Med Dosw (Online). 2017. PMID: 28894050 Review.
-
[Metabolic disorders in patients with psoriasis].Przegl Lek. 2011;68(12):1193-8. Przegl Lek. 2011. PMID: 22519279 Review. Polish.
-
[Psoriasis and comorbidity--literature review].Wiad Lek. 2014;67(4):512-9. Wiad Lek. 2014. PMID: 26030958 Review. Polish.
-
Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders.Int J Dermatol. 2017 Mar;56(3):260-268. doi: 10.1111/ijd.13420. Epub 2016 Oct 1. Int J Dermatol. 2017. PMID: 27696392 Review.
-
Psoriasis and the metabolic syndrome.Clin Dermatol. 2018 Jan-Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005. Epub 2017 Sep 8. Clin Dermatol. 2018. PMID: 29241748 Review.
Cited by
-
Severe Xerostomia Induced by Multiple Systemic Diseases in a Patient with Psoriasis Vulgaris: A Case Report and Literature Review.Int Med Case Rep J. 2024 Jan 31;17:77-88. doi: 10.2147/IMCRJ.S453097. eCollection 2024. Int Med Case Rep J. 2024. PMID: 38314323 Free PMC article.
-
Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic Arthritis.Biomedicines. 2022 Sep 24;10(10):2387. doi: 10.3390/biomedicines10102387. Biomedicines. 2022. PMID: 36289648 Free PMC article. Review.
-
miRNAs and exosomes in psoriasis: coordinating cytoskeleton dynamics and extracellular matrix remodeling.Front Cell Dev Biol. 2025 Jul 18;13:1608902. doi: 10.3389/fcell.2025.1608902. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40756258 Free PMC article. Review.
-
The Role of Gamma Delta T Lymphocytes in Physiological and Pathological Condition-Focus on Psoriasis, Atopic Dermatitis, Autoimmune Disorders, Cancer and Lymphomas.Int J Mol Sci. 2024 Jul 21;25(14):7960. doi: 10.3390/ijms25147960. Int J Mol Sci. 2024. PMID: 39063202 Free PMC article. Review.
-
Analysis of Clinical and Genetic Factors of Obesity and Psoriasis Concomitance-The Influence of Body Mass Composition, Prevalence of Mood Disorders, Environmental Factors and FTO Gene Polymorphisms (rs9939609, rs1558902).Biomedicines. 2024 Feb 25;12(3):517. doi: 10.3390/biomedicines12030517. Biomedicines. 2024. PMID: 38540130 Free PMC article.
References
-
- Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50:377–89. - PubMed
-
- Owczarczyk-Saczonek A, Placek W. Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders. Int J Dermatol. 2017;56:260–8. - PubMed
-
- Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366:1059–62. - PubMed
Publication types
LinkOut - more resources
Full Text Sources